We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

034020:KRXDoosan Enerbility Co., Ltd. Analysis

Data as of 2026-03-10 - not real-time

₩102,500.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Doosan Enerbility is trading at a forward P/E of 95.1, far above the industry average of 29.6, indicating a strong premium valuation. The stock sits above its 20‑day (97,000) and 50‑day (90,876) simple moving averages, supporting a bullish price trend, while the RSI of 56.3 suggests modest momentum without overbought pressure. However, the MACD histogram is negative (-510) and the signal line is higher than the MACD line, pointing to short‑term bearish pressure. Volume remains stable and the beta of 0.49 implies limited market‑wide volatility, yet the 30‑day volatility of nearly 90% and a max drawdown around -25% highlight notable price swings. The company’s fundamentals show robust revenue growth (14.3%) but a negative profit margin and a high debt‑to‑equity ratio (>60), while cash flow is positive but free cash flow is modest. No dividend is being paid, making income generation unlikely. Overall, the stock reflects high growth expectations embedded in a premium price, balanced by considerable valuation and operational risks.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Negative MACD histogram indicating short‑term bearish momentum
  • Stable volume supporting price resilience
  • High valuation compresses upside potential

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong revenue growth and expanding renewable‑energy portfolio
  • Bullish trend above key moving averages
  • Industry tailwinds in clean‑energy infrastructure

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Elevated forward P/E may limit long‑run returns
  • High debt level and modest free cash flow
  • Potential regulatory and geopolitical shifts affecting global energy projects

Key Metrics & Analysis

Financial Health

Revenue Growth14.30%
Profit Margin-0.61%
P/E Ratio95.1
ROE0.79%
ROA1.79%
Debt/Equity60.29
Op. Cash Flow₩545.3B
Free Cash Flow₩34.5B
Industry P/E29.6

Technical Analysis

TrendBullish
RSI56.3
Support₩79,000.00
Resistance₩110,200.00
MA 20₩97,000.00
MA 50₩90,876.00
MA 200₩71,884.75
MACDBearish
VolumeStable
Fear & Greed Index80.25

Valuation

Target Price₩116,944.45
Upside/Downside14.09%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta0.49
Volatility89.91%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.